Cargando…

Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies

Atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral arterial disease, represent a significant cause of premature death worldwide. Biomarkers, the evaluation of which would allow the detection of ASCVD at the earliest stage of de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surma, Stanisław, Banach, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745133/ https://www.ncbi.nlm.nih.gov/pubmed/35008616 http://dx.doi.org/10.3390/ijms23010193

Ejemplares similares

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023)

COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
por: Surma, Stanisław, et al.
Publicado: (2021)

Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Dietary salt intake and atherosclerosis: an area not fully explored
por: Banach, Maciej, et al.
Publicado: (2023)

A look to the past – what has had the biggest impact on lipids in the last four decades? A personal perspective
por: Banach, Maciej, et al.
Publicado: (2023)

Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation
por: Surma, Stanisław, et al.
Publicado: (2023)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Trained Immunity as a Trigger for Atherosclerotic Cardiovascular Disease—A Literature Review
por: Zieleniewska, Natalia Anna, et al.
Publicado: (2022)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Knowledge of Primary Care Patients Living in the Urban Areas about Risk Factors of Arterial Hypertension
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studies
por: Surma, Stanisław, et al.
Publicado: (2023)

Androgen therapy and atherosclerotic cardiovascular disease
por: McGrath, K-CY, et al.
Publicado: (2008)

Atherosclerotic Cardiovascular Disease Beginning in Childhood
por: Hong, Young Mi
Publicado: (2010)

Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?
por: Surma, Stanisław, et al.
Publicado: (2022)

Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular Disease
por: Surma, Stanisław, et al.
Publicado: (2022)

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies
por: Tada, Hayato, et al.
Publicado: (2018)

Periodontitis, Blood Pressure, and the Risk and Control of Arterial Hypertension: Epidemiological, Clinical, and Pathophysiological Aspects—Review of the Literature and Clinical Trials
por: Surma, Stanisław, et al.
Publicado: (2021)

Oral health and atherosclerotic cardiovascular disease: A review
por: Gianos, Eugenia, et al.
Publicado: (2021)

Cardiovascular magnetic resonance in carotid atherosclerotic disease
por: Dong, Li, et al.
Publicado: (2009)

Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
por: Wu, Hongxian, et al.
Publicado: (2018)

Novel Therapeutical Approaches to Managing Atherosclerotic Risk
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2021)

The Effect of a Vegan Diet on the Cardiovascular System
por: Koutentakis, Michail, et al.
Publicado: (2023)

Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
por: Poels, Kikkie, et al.
Publicado: (2021)

Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease
por: Nishikido, Toshiyuki
Publicado: (2023)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
por: Al Samarraie, Ahmad, et al.
Publicado: (2023)

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022)

Is colchicine the holy grail for treating inflammation and reducing cardiovascular risk?
por: Filipiak, Krzysztof J., et al.
Publicado: (2021)

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
por: Banach, Maciej, et al.
Publicado: (2022)

Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
por: Gluba-Brzózka, Anna, et al.
Publicado: (2016)

Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review
por: Deng, Qian, et al.
Publicado: (2020)

Endovascular treatments of atherosclerotic renovascular disease: a narrative review and literature search
por: Yeşiltaş, Mehmet Ali, et al.
Publicado: (2023)

GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
por: Mori, Yusaku, et al.
Publicado: (2020)

High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study
por: Quispe, Renato, et al.
Publicado: (2020)

Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress
por: Di Pietro, Marisa, et al.
Publicado: (2017)

Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases
por: Chen, Jingyuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_910j5bspspv2sao2mqi67863bn